top of page

Tue, Jan 10

|

Live Webinar

21 CFR Part 11 Guidance for Electronic Records and Electronic Signatures in FDA-Regulated Industries

There are very specific limitations that arise when using ER/ES capability, such as the elimination of print capability to prevent users from making decisions based on a paper record as opposed to the electronic record.

Registration is closed
See other events
21 CFR Part 11 Guidance for Electronic Records and Electronic Signatures in FDA-Regulated Industries
21 CFR Part 11 Guidance for Electronic Records and Electronic Signatures in FDA-Regulated Industries

Time & Location

Jan 10, 2023, 10:00 AM – 1:00 PM PST

Live Webinar

Share this event

bottom of page